Provided by Tiger Trade Technology Pte. Ltd.

Corvus Pharmaceuticals

13.88
-0.2800-1.98%
Volume:251.34K
Turnover:3.49M
Market Cap:1.16B
PE:-22.20
High:14.16
Open:14.09
Low:13.71
Close:14.16
52wk High:26.95
52wk Low:5.58
Shares:83.77M
Float Shares:74.12M
Volume Ratio:0.51
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6252
EPS(LYR):-0.5320
ROE:-35.43%
ROA:-21.66%
PB:5.16
PE(LYR):-26.09

Loading ...

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

GlobeNewswire
·
Apr 21

Goldman Sachs Initiates Corvus Pharmaceuticals at Buy With $40 Price Target

MT Newswires Live
·
Apr 17

Stock Track | Corvus Pharmaceuticals Plummets 10.61% Intraday on Dilution Fears from Expanded $200 Million ATM Facility

Stock Track
·
Mar 19

Is Corvus Pharmaceuticals’ Expanded US$200 Million ATM Facility Reframing Its Funding Story for CRVS?

Simply Wall St.
·
Mar 19

Mizuho Securities Sticks to Its Buy Rating for Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
Mar 16

Barclays Sticks to Their Buy Rating for Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
Mar 16

Corvus Pharmaceuticals Bets Big on Soquelitinib Pipeline

TIPRANKS
·
Mar 14

BUZZ - US STOCKS ON THE MOVE-Kyivstar Group, Applied Materials, Tevogen Bio

Reuters
·
Mar 14

Stock Track | Corvus Pharmaceuticals Plummets 5.18% Intraday on Expanded Stock Sale Agreement

Stock Track
·
Mar 13

Corvus Pharmaceuticals : Oppenheimer Raises Target Price to $33 From $32

THOMSON REUTERS
·
Mar 13

BUZZ-U.S. STOCKS ON THE MOVE-PayPay Corp, Ulta Beauty, InMode

Reuters
·
Mar 13

Corvus Pharmaceuticals Inc - Enters Amended Sales Agreement to Sell Common Stock up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Mar 13

Corvus Pharmaceuticals ups Jefferies ATM equity offering to USD 200 million

Reuters
·
Mar 13

Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer

TIPRANKS
·
Mar 13

Corvus Pharmaceuticals Inc Files for Mixed Shelf ; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 13

Corvus Pharmaceuticals Q4 Loss Narrows

MT Newswires Live
·
Mar 13

Earnings Flash (CRVS) Corvus Pharmaceuticals Posts Q4 Loss $-0.15, vs. FactSet Est of Loss of $-0.13

MT Newswires Live
·
Mar 13

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 11

Corvus Pharmaceuticals Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
Mar 11